A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs

Clinical trial NCT03201718 · COMPLETED

Trial details

NCT number: NCT03201718
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C Virus (HCV)

Start date: 2017-08-17
Primary completion: 2019-10-11
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.